Project

RA Bridge

Automatically Closed ยท 2019 until 2023

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2019
End Date
2023
Financing
Industry
Brief description/objective

A Randomized, Active-Controlled, Parallel-Group,
Phase 3b/4 Study of Baricitinib in Patients with
Rheumatoid Arthritis